Mayron Ron 4
4 · Wize Pharma, Inc. · Filed May 1, 2018
Insider Transaction Report
Form 4
Mayron Ron
Director
Transactions
- Award
Stock Option (right to buy)
2018-04-04+46,500→ 0 totalExercise: $3.59Exp: 2025-04-04→ Common Stock (46,500 underlying) - Award
Restricted Stock Units (RSUs)
2018-04-04+40,000→ 66,259 total
Footnotes (4)
- [F1]The RSUs were fully vested upon grant.
- [F2]The RSUs were granted as compensation for services as the Chairman of the Board of the Issuer.
- [F3]The Stock Option is exercisable in twelve equal installments over the three year period from the date of grant.
- [F4]The Stock Option was granted as compensation for services as the Chairman of the Board of the Issuer.